Home LiteratureArticle Details
PMID: 30559488 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Neurodevelopmental disease genes implicated by de novo mutation and copy number variation morbidity.

Nature genetics ·Vol. 51 ·No. 1 ·2019-00-00 ·Pages 106-116

Coe BP, Stessman HAF, Sulovari A, Geisheker MR, Bakken TE, Lake AM, Dougherty JD, Lein ES, Hormozdiari F, Bernier RA, Eichler EE

Abstract

We combined de novo mutation (DNM) data from 10,927 individuals with developmental delay and autism to identify 253 candidate neurodevelopmental disease genes with an excess of missense and/or likely gene-disruptive (LGD) mutations. Of these genes, 124 reach exome-wide significance (P < 5 × 10-7) for DNM. Intersecting these results with copy number variation (CNV) morbidity data shows an enrichment for genomic disorder regions (30/253, likelihood ratio (LR) +1.85, P = 0.0017). We identify genes with an excess of missense DNMs overlapping deletion syndromes (for example, KIF1A and the 2q37 deletion) as well as duplication syndromes, such as recurrent MAPK3 missense mutations within the chromosome 16p11.2 duplication, recurrent CHD4 missense DNMs in the 12p13 duplication region, and recurrent WDFY4 missense DNMs in the 10q11.23 duplication region. Network analyses of genes showing an excess of DNMs highlights functional networks, including cell-specific enrichments in the D1+ and D2+ spiny neurons of the striatum.

MeSH Terms
Animals Autistic Disorder/genetics Chromosome Aberrations DNA Copy Number Variations/genetics Developmental Disabilities/genetics Exome/genetics Humans Intellectual Disability/genetics Intracellular Signaling Peptides and Proteins/genetics Mi-2 Nucleosome Remodeling and Deacetylase Complex/genetics Mice Mutation/genetics Neurodevelopmental Disorders/genetics Phenotype Polymorphism, Single Nucleotide/genetics
Chemicals
Intracellular Signaling Peptides and Proteins Mi-2 Nucleosome Remodeling and Deacetylase Complex
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Coe Bradley P
Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA.
Stessman Holly A F
Department of Pharmacology, Creighton University Medical School, Omaha, NE, USA.
Sulovari Arvis
Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA.
Geisheker Madeleine R
Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA.
Bakken Trygve E
Allen Institute for Brain Science, Seattle, WA, USA.
Lake Allison M
Department of Genetics, Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
Dougherty Joseph D ORCID
Department of Genetics, Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
Lein Ed S ORCID
Allen Institute for Brain Science, Seattle, WA, USA.
Hormozdiari Fereydoun
Department of Biochemistry and Molecular Medicine, University of California, Davis, Davis, CA, USA.
Bernier Raphael A
Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA.
Eichler Evan E ORCID
Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA. [email protected]. | Howard Hughes Medical Institute, University of Washington, Seattle, WA, USA. [email protected].
References (99)
99 references, click to expand
  1. Mapping autosomal recessive intellectual disability: combined microarray and exome sequencing identifies 26 novel candidate genes in 192 consanguineous families.
    Mol Psychiatry. 2018 Apr;23(4):973-984 PMID: 28397838
  2. Whole-genome sequencing in autism identifies hot spots for de novo germline mutation.
    Cell. 2012 Dec 21;151(7):1431-42 PMID: 23260136
  3. MAPK3 at the Autism-Linked Human 16p11.2 Locus Influences Precise Synaptic Target Selection at Drosophila Larval Neuromuscular Junctions.
    Mol Cells. 2017 Feb;40(2):151-161 PMID: 28196412
  4. Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes.
    Nat Genet. 2010 Nov;42(11):1021-6 PMID: 20890276
  5. A microdeletion encompassing PHF21A in an individual with global developmental delay and craniofacial anomalies.
    Am J Med Genet A. 2015 Dec;167A(12):3011-8 PMID: 26333423
  6. Chd8 Mutation Leads to Autistic-like Behaviors and Impaired Striatal Circuits.
    Cell Rep. 2017 Apr 11;19(2):335-350 PMID: 28402856
  7. Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders.
    Am J Med Genet B Neuropsychiatr Genet. 2010 Jun 5;153B(4):937-47 PMID: 20468056
  8. Association between a GABRB3 polymorphism and autism.
    Mol Psychiatry. 2002;7(3):311-6 PMID: 11920158
  9. Reversal of dendritic phenotypes in 16p11.2 microduplication mouse model neurons by pharmacological targeting of a network hub.
    Proc Natl Acad Sci U S A. 2016 Jul 26;113(30):8520-5 PMID: 27402753
  10. De novo missense variants in HECW2 are associated with neurodevelopmental delay and hypotonia.
    J Med Genet. 2017 Feb;54(2):84-86 PMID: 27389779
  11. Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations.
    Am J Med Genet A. 2016 Dec;170(12):3069-3082 PMID: 27648933
  12. Intellectual disability and its relationship to autism spectrum disorders.
    Res Dev Disabil. 2009 Nov-Dec;30(6):1107-14 PMID: 19604668
  13. Brain structure. Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq.
    Science. 2015 Mar 6;347(6226):1138-42 PMID: 25700174
  14. Fine-scale structural variation of the human genome.
    Nat Genet. 2005 Jul;37(7):727-32 PMID: 15895083
  15. MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations.
    J Med Genet. 2010 Jan;47(1):22-9 PMID: 19592390
  16. Hotspots of missense mutation identify neurodevelopmental disorder genes and functional domains.
    Nat Neurosci. 2017 Aug;20(8):1043-1051 PMID: 28628100
  17. Analytical approaches to RNA profiling data for the identification of genes enriched in specific cells.
    Nucleic Acids Res. 2010 Jul;38(13):4218-30 PMID: 20308160
  18. A framework for the interpretation of de novo mutation in human disease.
    Nat Genet. 2014 Sep;46(9):944-50 PMID: 25086666
  19. Suppression of Sin3A activity promotes differentiation of pluripotent cells into functional neurons.
    Sci Rep. 2017 Mar 17;7:44818 PMID: 28303954
  20. Genomic Patterns of De Novo Mutation in Simplex Autism.
    Cell. 2017 Oct 19;171(3):710-722.e12 PMID: 28965761
  21. Diagnostic genome profiling in mental retardation.
    Am J Hum Genet. 2005 Oct;77(4):606-16 PMID: 16175506
  22. Disruptive CHD8 mutations define a subtype of autism early in development.
    Cell. 2014 Jul 17;158(2):263-276 PMID: 24998929
  23. The 2q37-deletion syndrome: an update of the clinical spectrum including overweight, brachydactyly and behavioural features in 14 new patients.
    Eur J Hum Genet. 2013 Jun;21(6):602-12 PMID: 23073310
  24. First glimpses of the neurobiology of autism spectrum disorder.
    Curr Opin Genet Dev. 2015 Aug;33:80-92 PMID: 26547130
  25. Interstitial microdeletion of 4p16.3: contribution of WHSC1 haploinsufficiency to the pathogenesis of developmental delay in Wolf-Hirschhorn syndrome.
    Am J Med Genet A. 2010 Apr;152A(4):1028-32 PMID: 20358621
  26. De Novo Mutations in YWHAG Cause Early-Onset Epilepsy.
    Am J Hum Genet. 2017 Aug 3;101(2):300-310 PMID: 28777935
  27. Whole-Exome Sequencing in a South American Cohort Links ALDH1A3, FOXN1 and Retinoic Acid Regulation Pathways to Autism Spectrum Disorders.
    PLoS One. 2015 Sep 09;10(9):e0135927 PMID: 26352270
  28. PQBP1, a factor linked to intellectual disability, affects alternative splicing associated with neurite outgrowth.
    Genes Dev. 2013 Mar 15;27(6):615-26 PMID: 23512658
  29. The 16p11.2 deletion mouse model of autism exhibits altered cortical progenitor proliferation and brain cytoarchitecture linked to the ERK MAPK pathway.
    J Neurosci. 2015 Feb 18;35(7):3190-200 PMID: 25698753
  30. Analysis of protein-coding genetic variation in 60,706 humans.
    Nature. 2016 Aug 17;536(7616):285-91 PMID: 27535533
  31. denovo-db: a compendium of human de novo variants.
    Nucleic Acids Res. 2017 Jan 4;45(D1):D804-D811 PMID: 27907889
  32. CLTC as a clinically novel gene associated with multiple malformations and developmental delay.
    Am J Med Genet A. 2016 Apr;170A(4):958-66 PMID: 26822784
  33. Integrated model of de novo and inherited genetic variants yields greater power to identify risk genes.
    PLoS Genet. 2013;9(8):e1003671 PMID: 23966865
  34. De novo SCN2A splice site mutation in a boy with Autism spectrum disorder.
    BMC Med Genet. 2014 Mar 20;15:35 PMID: 24650168
  35. Mutations of RAI1, a PHD-containing protein, in nondeletion patients with Smith-Magenis syndrome.
    Hum Genet. 2004 Nov;115(6):515-24 PMID: 15565467
  36. Connectivity-based parcellation reveals distinct cortico-striatal connectivity fingerprints in Autism Spectrum Disorder.
    Neuroimage. 2018 Apr 15;170:412-423 PMID: 28188914
  37. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.
    Nat Genet. 1999 Oct;23(2):185-8 PMID: 10508514
  38. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function.
    Nucleic Acids Res. 2010 Jul;38(Web Server issue):W214-20 PMID: 20576703
  39. Whole-exome sequencing and neurite outgrowth analysis in autism spectrum disorder.
    J Hum Genet. 2016 Mar;61(3):199-206 PMID: 26582266
  40. Prevalence and architecture of de novo mutations in developmental disorders.
    Nature. 2017 Feb 23;542(7642):433-438 PMID: 28135719
  41. The clinical significance of small copy number variants in neurodevelopmental disorders.
    J Med Genet. 2014 Oct;51(10):677-88 PMID: 25106414
  42. MEF2C regulates cortical inhibitory and excitatory synapses and behaviors relevant to neurodevelopmental disorders.
    Elife. 2016 Oct 25;5: PMID: 27779093
  43. Recurrent reciprocal copy number variants: Roles and rules in neurodevelopmental disorders.
    Dev Neurobiol. 2018 May;78(5):519-530 PMID: 29575775
  44. Foxp2 controls synaptic wiring of corticostriatal circuits and vocal communication by opposing Mef2c.
    Nat Neurosci. 2016 Nov;19(11):1513-1522 PMID: 27595386
  45. Proteomic Analysis of Post-synaptic Density Fractions from Shank3 Mutant Mice Reveals Brain Region Specific Changes Relevant to Autism Spectrum Disorder.
    Front Mol Neurosci. 2017 Feb 14;10:26 PMID: 28261056
  46. Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases.
    Nat Genet. 2017 Apr;49(4):515-526 PMID: 28191889
  47. Pathogenic ASXL1 somatic variants in reference databases complicate germline variant interpretation for Bohring-Opitz Syndrome.
    Hum Mutat. 2017 May;38(5):517-523 PMID: 28229513
  48. De novo genic mutations among a Chinese autism spectrum disorder cohort.
    Nat Commun. 2016 Nov 08;7:13316 PMID: 27824329
  49. Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci.
    Neuron. 2015 Sep 23;87(6):1215-1233 PMID: 26402605
  50. Segmental duplications and copy-number variation in the human genome.
    Am J Hum Genet. 2005 Jul;77(1):78-88 PMID: 15918152
  51. Clinical studies on submicroscopic subtelomeric rearrangements: a checklist.
    J Med Genet. 2001 Mar;38(3):145-50 PMID: 11238680
  52. De Novo Truncating Mutations in the Last and Penultimate Exons of PPM1D Cause an Intellectual Disability Syndrome.
    Am J Hum Genet. 2017 Apr 6;100(4):650-658 PMID: 28343630
  53. A copy number variation morbidity map of developmental delay.
    Nat Genet. 2011 Aug 14;43(9):838-46 PMID: 21841781
  54. Molecular and clinical delineation of 2p15p16.1 microdeletion syndrome.
    Am J Med Genet A. 2017 Aug;173(8):2081-2087 PMID: 28573701
  55. Genome Sequencing of Autism-Affected Families Reveals Disruption of Putative Noncoding Regulatory DNA.
    Am J Hum Genet. 2016 Jan 7;98(1):58-74 PMID: 26749308
  56. Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder.
    Nat Neurosci. 2017 Apr;20(4):602-611 PMID: 28263302
  57. Large-scale discovery of novel genetic causes of developmental disorders.
    Nature. 2015 Mar 12;519(7542):223-8 PMID: 25533962
  58. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations.
    Nat Genet. 2011 Jun;43(6):585-9 PMID: 21572417
  59. The Koolen-de Vries syndrome: a phenotypic comparison of patients with a 17q21.31 microdeletion versus a KANSL1 sequence variant.
    Eur J Hum Genet. 2016 May;24(5):652-9 PMID: 26306646
  60. A de novo POU3F3 Deletion in a Boy with Intellectual Disability and Dysmorphic Features.
    Mol Syndromol. 2014 Jan;5(1):32-5 PMID: 24550763
  61. Proteins linked to autosomal dominant and autosomal recessive disorders harbor characteristic rare missense mutation distribution patterns.
    Hum Mol Genet. 2015 Nov 1;24(21):5995-6002 PMID: 26246501
  62. Segmental duplications: organization and impact within the current human genome project assembly.
    Genome Res. 2001 Jun;11(6):1005-17 PMID: 11381028
  63. Mutations in HECW2 are associated with intellectual disability and epilepsy.
    J Med Genet. 2016 Oct;53(10):697-704 PMID: 27334371
  64. Synaptic, transcriptional and chromatin genes disrupted in autism.
    Nature. 2014 Nov 13;515(7526):209-15 PMID: 25363760
  65. Haploinsufficiency of BCL11A associated with cerebellar abnormalities in 2p15p16.1 deletion syndrome.
    Mol Genet Genomic Med. 2017 May 22;5(4):429-437 PMID: 28717667
  66. STAR: ultrafast universal RNA-seq aligner.
    Bioinformatics. 2013 Jan 1;29(1):15-21 PMID: 23104886
  67. Cell type-specific expression analysis to identify putative cellular mechanisms for neurogenetic disorders.
    J Neurosci. 2014 Jan 22;34(4):1420-31 PMID: 24453331
  68. Diagnostic exome sequencing in persons with severe intellectual disability.
    N Engl J Med. 2012 Nov 15;367(20):1921-9 PMID: 23033978
  69. Discovery and Replication of Gene Influences on Brain Structure Using LASSO Regression.
    Front Neurosci. 2012 Aug 06;6:115 PMID: 22888310
  70. Genome-wide characteristics of de novo mutations in autism.
    NPJ Genom Med. 2016 Aug 3;1:160271-1602710 PMID: 27525107
  71. A general framework for estimating the relative pathogenicity of human genetic variants.
    Nat Genet. 2014 Mar;46(3):310-5 PMID: 24487276
  72. The discovery of integrated gene networks for autism and related disorders.
    Genome Res. 2015 Jan;25(1):142-54 PMID: 25378250
  73. A Novel Human CAMK2A Mutation Disrupts Dendritic Morphology and Synaptic Transmission, and Causes ASD-Related Behaviors.
    J Neurosci. 2017 Feb 22;37(8):2216-2233 PMID: 28130356
  74. Shared Motivational Functions of Ventral Striatum D1 and D2 Medium Spiny Neurons.
    J Neurosci. 2017 Jun 28;37(26):6177-6179 PMID: 28659329
  75. Exome sequencing identifies de novo gain of function missense mutation in KCND2 in identical twins with autism and seizures that slows potassium channel inactivation.
    Hum Mol Genet. 2014 Jul 1;23(13):3481-9 PMID: 24501278
  76. An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities.
    Genet Med. 2011 Sep;13(9):777-84 PMID: 21844811
  77. MEF2C Haploinsufficiency features consistent hyperkinesis, variable epilepsy, and has a role in dorsal and ventral neuronal developmental pathways.
    Neurogenetics. 2013 May;14(2):99-111 PMID: 23389741
  78. The contribution of de novo coding mutations to autism spectrum disorder.
    Nature. 2014 Nov 13;515(7526):216-21 PMID: 25363768
  79. KIF1A missense mutations in SPG30, an autosomal recessive spastic paraplegia: distinct phenotypes according to the nature of the mutations.
    Eur J Hum Genet. 2012 Jun;20(6):645-9 PMID: 22258533
  80. Excess of rare, inherited truncating mutations in autism.
    Nat Genet. 2015 Jun;47(6):582-8 PMID: 25961944
  81. Varying Intolerance of Gene Pathways to Mutational Classes Explain Genetic Convergence across Neuropsychiatric Disorders.
    Cell Rep. 2017 Feb 28;18(9):2217-2227 PMID: 28249166
  82. Smaller and larger deletions of the Williams Beuren syndrome region implicate genes involved in mild facial phenotype, epilepsy and autistic traits.
    Eur J Hum Genet. 2014 Jan;22(1):64-70 PMID: 23756441
  83. Identification of a novel de novo nonsense mutation of the NSD1 gene in monozygotic twins discordant for Sotos syndrome.
    Clin Chim Acta. 2017 Jul;470:31-35 PMID: 28457852
  84. Potocki-Shaffer syndrome in a child without intellectual disability-The role of PHF21A in cognitive function.
    Am J Med Genet A. 2017 Mar;173(3):716-720 PMID: 28127865
  85. Humanized Foxp2 accelerates learning by enhancing transitions from declarative to procedural performance.
    Proc Natl Acad Sci U S A. 2014 Sep 30;111(39):14253-8 PMID: 25225386
  86. A genotype-first approach to defining the subtypes of a complex disease.
    Cell. 2014 Feb 27;156(5):872-7 PMID: 24581488
  87. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders.
    Science. 2012 Dec 21;338(6114):1619-22 PMID: 23160955
  88. Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype.
    J Med Genet. 2009 Sep;46(9):598-606 PMID: 19264732
  89. De Novo Mutations in CHD4, an ATP-Dependent Chromatin Remodeler Gene, Cause an Intellectual Disability Syndrome with Distinctive Dysmorphisms.
    Am J Hum Genet. 2016 Oct 6;99(4):934-941 PMID: 27616479
  90. Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability.
    Nat Neurosci. 2016 Sep;19(9):1194-6 PMID: 27479843
  91. Refining analyses of copy number variation identifies specific genes associated with developmental delay.
    Nat Genet. 2014 Oct;46(10):1063-71 PMID: 25217958
  92. Recurrent 16p11.2 microdeletions in autism.
    Hum Mol Genet. 2008 Feb 15;17(4):628-38 PMID: 18156158
  93. The Deciphering Developmental Disorders (DDD) study.
    Dev Med Child Neurol. 2011 Aug;53(8):702-3 PMID: 21679367
  94. KCNA4 deficiency leads to a syndrome of abnormal striatum, congenital cataract and intellectual disability.
    J Med Genet. 2016 Nov;53(11):786-792 PMID: 27582084
  95. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study.
    Lancet. 2012 Nov 10;380(9854):1674-82 PMID: 23020937
  96. Changes in the development of striatum are involved in repetitive behavior in autism.
    Biol Psychiatry. 2014 Sep 1;76(5):405-11 PMID: 24090791
  97. Strong association of de novo copy number mutations with autism.
    Science. 2007 Apr 20;316(5823):445-9 PMID: 17363630
  98. Haploinsufficiency of MeCP2-interacting transcriptional co-repressor SIN3A causes mild intellectual disability by affecting the development of cortical integrity.
    Nat Genet. 2016 Aug;48(8):877-87 PMID: 27399968
  99. Spatial Clustering of de Novo Missense Mutations Identifies Candidate Neurodevelopmental Disorder-Associated Genes.
    Am J Hum Genet. 2017 Sep 7;101(3):478-484 PMID: 28867141
Article Info
Journal
Nature genetics
Abbr.
Nat Genet
ISSN
1546-1718
Published
2019-00-00
Epub
2018-00-17
Pages
106-116
Language
English
Region
United States
NLM ID
9216904
PMCID
PMC6309590
Subset
IM
Grants
NICHD NIH HHS · U54 HD087011 · United States
Howard Hughes Medical Institute · United States
NIGMS NIH HHS · T32 GM007266 · United States
NIMH NIH HHS · R01 MH101221 · United States
NIMH NIH HHS · R01 MH107515 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]